New study center in Hamburg

The Asklepios Klinik St. Georg in Hamburg has recently been recruited as a new study center for the Post Market Clinical Follow-Up Study (PMCF study).

After clinical proof of concept in an observational study at the The Medical Center – University of Freiburg, CE approval of the CARL System followed in 2020, as well as the start of the PMCF study at initially four European centers. The following twelve study centers are now participating in the study: